课题基金 / 基金详情

ANTIFUMOR EFFECT OF OLIGONUCLEOTIDE ENTLRAPPED-LIPOSOMES AGAINST THE DIGESTRE ORGAN CANCER.

ANTIFUMOR EFFECT OF OLIGONUCLEOTIDE ENTLRAPPED-LIPOSOMES AGAINST THE DIGESTRE ORGAN CANCER.
寡核苷酸包埋脂质体对消化器官癌的抗肿瘤作用。
批准号:
05671001
负责人:
KONNO Hiroyuki
金额:
$1.41万
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (C)
财政年份:
1993
资助国家:
日本
项目状态:
已结题
起止时间:
1993 至 1995

项目摘要

项目成果

KONNO Hiroyuki的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
1. We established the liver metastatic model of human colon cancer strains, TK-3, -4, -6, -9, -10, -13 by using orthotopical transplantation, in which liver metastatic rate was from 38% to 83%. The point mutation of p53 was observed in TK-4 and the deletion of p53 was observed in TK-13. We could establish the stable liver metastatic model, because liver metastatic lesions, which were considered to have high malignant potential, were used for initial establisjhment of the 6 strains.2. Hepatotropic liposomes were prepared to enhance the uptake of entrapped genes into liver. To investigate the usefulness of hepatotropic liposomes, adriamycin (ADM) instead of p53 genes was entrapped in to liposomes (hLip-ADM). ADM concentration of the liver after the administration of hLip-ADM was significantly higher than that after administration of free ADM (unentrapped ADM) or cLip-ADM {ADM entrapped in control (non-hepatotropic) liposome}. Regarding the therapeutic effect, the administration of cLip-ADM decreased the liver metastasis to 42.9% and hLip-ADM inhibited the liver metastasis of TK-4 completely, whereas liver metastasis developed in 85.7% of the control after orthotopical transplantation.3. We have been tried to prepare the liposomes entrapped the human wild type p53 plasmid, instead of nucreotides, based on the results of our preliminary experiments and the studies reported recently. The human wild type p53 plasmid could be prepared by using pRC/CMV as the vector. However, we can not show the therapeutic effect of hLip-p53 (wild type p53 entrapped in hepatotropic liposome) on liver metastasis, so far. Antiproliferative effect and antimetastatic effect of hLip-p53 will be examined in the in vitro and in vivo experiments.
期刊论文(18)
专著(0)
科研奖励(0)
会议论文
Tanaka T.: "Prevention of nepatic metasis of human colon Cancer by angiogenesis inhibitor TNP-470." Can Res.55. 836-839 (1995)
Tanaka T.:“通过血管生成抑制剂 TNP-470 预防人类结肠癌的肾转移。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Konno H.: "Comparison of the inhibitory effect of angiogenesis inhibitor, TNP-470, and mitomycin C on the growth andliver metasis of human colon cancer." Int.J.Cancer. 61. 268-271 (1995)
Konno H.:“血管生成抑制剂 TNP-470 和丝裂霉素 C 对人结肠癌生长和肝转移的抑制作用比较。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Konno H.: "Efficacy of an angiogenesis inhibitor, TNP-470, in xenotransplanted human colorectal cancer with high metastatic potential" Cancer. 77 (in press). (1996)
Konno H.:“血管生成抑制剂 TNP-470 在具有高转移潜力的异种移植人类结直肠癌中的功效”癌症。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
14
    Alterations of tumor microenvironment during antiangiogenic therapy in colorectal cancer
    • 批准号:
      24390312
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.73万
    • 财政年份:
      2012
    • 负责人:
      KONNO Hiroyuki
    • 依托单位:
    Novel strategies for cancer therapy targeting premetastatic niche
    • 批准号:
      21390376
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $8.49万
    • 财政年份:
      2009
    • 负责人:
      KONNO Hiroyuki
    • 依托单位:
    Design and synthesis of the inhibitors for chemokine receptor CCR5
    • 批准号:
      21689004
    • 项目类别:
      Grant-in-Aid for Young Scientists (A)
    • 资助金额:
      $17.64万
    • 财政年份:
      2009
    • 负责人:
      KONNO Hiroyuki
    • 依托单位:
    Synthesis and inhibitory activity of cyclic depsi-peptide with anti-HIV activity
    • 批准号:
      19790095
    • 项目类别:
      Grant-in-Aid for Young Scientists (B)
    • 资助金额:
      $2.32万
    • 财政年份:
      2007
    • 负责人:
      KONNO Hiroyuki
    • 依托单位: